Real-time enrollment status for this blood cancer clinical trial
Current Status
Completed
Checked: April 18, 2026 at 12:24 AM UTC
| NCT Number | NCT06492304 |
| Recruiting Status | Completed |
| Condition | Blood Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 290 participants |
| Active Locations | 6 sites in the US |
| Sponsor | CRISPR Therapeutics |
| Last Updated on CT.gov | April 3, 2026 (2 weeks ago) |
As of April 18, 2026: Clinical trial NCT06492304 is currently completed participants. This clinical trial study for blood cancer is not currently accepting new participants at 6 locations across the United States. The study is sponsored by CRISPR Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06492304 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06492304 was last updated 2 weeks ago (April 3, 2026). HelloStudys verifies this status automatically.